New acute treatments for headache

Por Rapoport, Alan M.
Publicado em 2010

Cluster headache in Greece: an observational clinical and demographic study of 302 patients

Por Vikelis, Michail, Rapoport, Alan M.
Publicado no J Headache Pain (2016)

Diclofenac potassium for oral solution (CAMBIA(®)) in the acute management of a migraine attack: clinical evidence and practical experience

Por Joshi, Shivang, Rapoport, Alan M.
Publicado no Ther Adv Neurol Disord (2017)

Hemicrania continua

Por Rapoport, Alan M., Bigal, Marcello E.
Publicado em 2004

All triptans are not the same

Por Rapoport, Alan M., Tepper, Stewart J.
Publicado em 2001

New players in the preventive treatment of migraine

Por Mitsikostas, Dimos D., Rapoport, Alan M.
Publicado no BMC Med (2015)

Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine

Por Vikelis, Michail, Mitsikostas, Dimos D, Rapoport, Alan M
Publicado em 2012

Strategies of care for acute treatment of migraine

Por Tepper, Stewart J., Rapoport, Alan M., Sheftell, Fred
Publicado em 2002

Migraine and Obesity: Epidemiology, Mechanisms, and Implications

Por Peterlin, B. Lee, Rapoport, Alan M., Kurth, Tobias
Publicado em 2009

Therapeutic antibodies against CGRP or its receptor

Por Bigal, Marcelo E, Walter, Sarah, Rapoport, Alan M
Publicado no Br J Clin Pharmacol (2015)

The iontophoretic transdermal system formulation of sumatriptan as a new option in the acute treatment of migraine: a perspective

Por Vikelis, Michail, Spingos, Konstantinos C., Rapoport, Alan M.
Publicado no Ther Adv Neurol Disord (2015)

ACUTE AND PREVENTIVE PHARMACOLOGIC TREATMENT OF CLUSTER HEADACHE

Por Peterlin, B. Lee, Purdy, R. Allan, Rapoport, Alan M.
Publicado no Neurology (2011)

The effect of weight, body mass index, age, sex, and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysis

Por Munjal, Sagar, Gautam, Anirudh, Rapoport, Alan M, Fisher, Dennis M
Publicado no Clin Pharmacol (2016)

Obesity and Migraine: The Effect of Age, Gender and Adipose Tissue Distribution

Por Peterlin, B. Lee, Rosso, Andrea L., Rapoport, Alan M., Scher, Ann I.
Publicado em 2009

Levetiracetam in the preventive treatmentof transformed migraine: A prospective, open-label, pilot study

Por Rapoport, Alan M., Sheftell, Fred D., Tepper, Stewart J., Bigal, Marcelo E.
Publicado em 2005

The Association of Obesity With Episodic and Chronic Migraine

Por Evans, Randolph W., Williams, Michelle A., Rapoport, Alan M., Peterlin, B. Lee
Publicado em 2012

A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of epis...

Por Munjal, Sagar, Brand-Schieber, Elimor, Allenby, Kent, Spierings, Egilius L.H., Cady, Roger K., Rapoport, Alan M.
Publicado no J Headache Pain (2017)

Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification

Por Charles, James A., Peterlin, B. L., Rapoport, Alan M., Linder, Steven L., Kabbouche, Marielle A., Sheftell, Fred D.
Publicado em 2009